Skip to Content

Atomo Diagnostics Ltd Ordinary Shares AT1

Morningstar Rating
A$0.03 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AT1 is trading at a 63% discount.
Price
A$0.03
Fair Value
A$9.52
Uncertainty
Extreme
1-Star Price
A$1.97
5-Star Price
A$5.82
Economic Moat
Prdp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AT1 is a good fit for your portfolio.

Trading Information

Previous Close Price
A$0.03
Day Range
A$0.030.03
52-Week Range
A$0.020.10
Bid/Ask
A$0.03 / A$0.03
Market Cap
A$19.18 Mil
Volume/Avg
279,718 / 1.6 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
5.79
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company develops the point of care devices for rapid diagnostic testing. Its device is used to test infectious diseases including COVID-19, viral vs bacterial differentiation and female health. Its offers AtomoRapid RDP Platform with devices including Galileo, Pascal, Newton, Losev, Franklin and Elion. The firm operates in a single segment, medical device research and development.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
AT1
Price/Earnings (Normalized)
Price/Book Value
1.40
Price/Sales
5.79
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
AT1
Quick Ratio
7.06
Current Ratio
8.69
Interest Coverage
−576.49
Quick Ratio
AT1

Profitability

Metric
AT1
Return on Assets (Normalized)
−42.41%
Return on Equity (Normalized)
−46.08%
Return on Invested Capital (Normalized)
−46.11%
Return on Assets
AT1
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesWklmpyqKnnnfy$185.4 Bil
SYK
Stryker CorpRrybthdvmGnr$128.2 Bil
BSX
Boston Scientific CorpHsxcywccWhrqlm$107.7 Bil
MDT
Medtronic PLCCgtltgyzfFdvtjp$105.2 Bil
DXCM
DexCom IncMmzfbxqvpNnp$54.7 Bil
EW
Edwards Lifesciences CorpWnpdjyygpvJfzpbs$52.8 Bil
ZBH
Zimmer Biomet Holdings IncHjgmxjpwtCbhk$24.6 Bil
ALGN
Align Technology IncRzqcjnfgFsyyfrj$23.4 Bil
PHG
Koninklijke Philips NV ADRFlmvwcbhtLzkyvm$18.7 Bil
PODD
Insulet CorpYgzmzqtkfZnmynt$11.5 Bil

Sponsor Center